Loading organizations...
WCTI Partners operates as a venture capital firm, providing capital and strategic guidance to emerging enterprises. The firm concentrates on seed and early-stage investments, targeting high-tech, information and communication technologies, healthcare, and cleantech sectors. Its strength lies in identifying and fostering innovative companies with significant market disruption potential.
Established in Philadelphia in 2005, WCTI Partners began with a clear focus on the early-stage technology ecosystem. The firm's inception was driven by recognizing the need for dedicated investment and mentorship. This approach helps advance foundational innovations through critical development phases, aiming to transition nascent ideas into viable market solutions.
WCTI Partners actively supports ambitious entrepreneurs and their ventures, serving as a crucial partner in their growth. The firm envisions cultivating a robust portfolio of groundbreaking companies through targeted capital and expertise. Its long-term goal is to contribute to advancements within its chosen industries and shape future technological progress.
WCTI Partners has 1 tracked investment across 1 company. The latest tracked deal is $6.0M Series A in Hemovent in February 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 10, 2016 | Hemovent | $6.0M Series A | Matthias Guth | KFW, NRW.Venture, PB Beteiligung UND Vermoegensverwaltung, Seed Fonds Aachen |